Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients

References

• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408–427.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288–294.
   PubMed Web of Science ®Google Scholar
• Reilly MM, Adams D, Booth DR, Davis MB, Said G, Laubriat-Bianchin M, Pepys MB, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118 (Pt 4):849–856.
   PubMedGoogle Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001–1007.
   PubMed Web of Science ®Google Scholar
• Munar-Qués M, Costa PP, Saraiva MJ, Viader-Farré C, Munar-Bernat C. [Familial type I (Portuguese form) amyloidotic polyneuropathy in Majorca. Study using the TTR (Met30) genetic marker]. Med Clin (Barc) 1988;91:441–444.
   PubMedGoogle Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512–521.
   PubMed Web of Science ®Google Scholar
• Benson MD, Cohen AS. Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med 1977;86:419–424.
   PubMed Web of Science ®Google Scholar
• Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–1062.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983;96:261–270.
   PubMedGoogle Scholar
• Monaco HL. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000;1482:65–72.
   PubMedGoogle Scholar
• Dwork AJ, Cavallaro T, Martone RL, Goodman DS, Schon EA, Herbert J. Distribution of transthyretin in the rat eye. Invest Ophthalmol Vis Sci 1990;31:489–496.
   PubMed Web of Science ®Google Scholar
• Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005;81:306–312.
   PubMed Web of Science ®Google Scholar
• Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54–69.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients’ survival. Liver Transpl 2009;15:1229–1235.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007;7:2597–2604.
   PubMed Web of Science ®Google Scholar
• Suhr OB, Friman S, Ericzon BG. Early liver transplantation improves familial amyloidotic polyneuropathy patients’ survival. Amyloid 2005;12:233–238.
   PubMed Web of Science ®Google Scholar
• Jonsén E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients’ quality of life. Amyloid 2001;8:52–57.
   PubMed Web of Science ®Google Scholar
• Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520–524.
   PubMed Web of Science ®Google Scholar
• Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000;7:266–269.
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 2002;9:247–251.
   PubMed Web of Science ®Google Scholar
• Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206–210.
   PubMedGoogle Scholar
• Sandgren O, Stenkula S, Dedorsson I. Vitreous surgery in patients with primary neuropathic amyloidosis. Acta Ophthalmol (Copenh) 1985;63:383–388.
   PubMedGoogle Scholar
• Doft BH, Machemer R, Skinner M, Buettner H, Clarkson J, Crock J, McLeod D, et al. Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology 1987;94:607–611.
   PubMed Web of Science ®Google Scholar
• Monteiro JG, Martins AF, Figueira A, Saraiva MJ, Costa PP. Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities. Eye (Lond) 1991;5 (Pt 1):99–105.
   PubMedGoogle Scholar
• Koga T, Ando E, Hirata A, Fukushima M, Kimura A, Ando Y, Negi A, Tanihara H. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188–193.
   PubMed Web of Science ®Google Scholar
• Beirão NM, Matos E, Beirão I, Costa PP, Torres P. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M. Retina (Philadelphia, Pa) 2011;31:1373–1377.
   PubMedGoogle Scholar
• Frau E, Lautier-Frau M, Saindelle-Ribeaudeau F, Adams D, Bousquet A, Labétoulle M, Offret H. [Familial amyloid polyneuropathy type I complicated by chronic glaucoma: 3 cases]. J Fr Ophthalmol 2000;23:217–220.
   PubMedGoogle Scholar
• Vella FS, Simone B, Giannelli G, Sisto D, Sborgia C, Antonaci S. Glaucoma in primary amyloidosis: a fortuitous or causative association? Am J Med 2002;113:252–254.
   PubMedGoogle Scholar
• Kawaji T, Ando Y, Hara R, Tanihara H. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology 2010;117:552–555.
   PubMed Web of Science ®Google Scholar
• Silva-Araújo AC, Tavares MA, Cotta JS, Castro-Correia JF. Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type. Graefes Arch Clin Exp Ophthalmol 1993;231:131–135.
   PubMedGoogle Scholar
• Miyahara T, Ohta K, Yamamoto Y, Ueno A, Murata T. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy. J Glaucoma 2007;16:169–170.
   PubMedGoogle Scholar
• Kawaji T, Ando Y, Hara R, Tanihara H. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology 2010;117:552–555.
   PubMed Web of Science ®Google Scholar
• Grus FH, Joachim SC, Sandmann S, Thiel U, Bruns K, Lackner KJ, Pfeiffer N. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 2008;14:1437–1445.
   PubMed Web of Science ®Google Scholar
• Kimura A, Ando E, Fukushima M, Koga T, Hirata A, Arimura K, Ando Y, et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol 2003;121:351–356.
   PubMedGoogle Scholar
• Yu AL, Brummeisl W, Schaumberger M, Kampik A, Welge-Lussen U. Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension–a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol 2010;248:1407–1414.
   PubMedGoogle Scholar
• Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol 2006;141:1033–1043.
   PubMed Web of Science ®Google Scholar
• Tezel G. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res 2011;93:178–186.
   PubMed Web of Science ®Google Scholar
• Oshida E, Matsumoto Y, Arai K. Free radicals in the aqueous humor of patients with glaucoma. Clin Ophthalmol 2010;4:653–660.
   PubMedGoogle Scholar
• Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH, Kaplan HJ. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 2010;51:5071–5082.
   PubMed Web of Science ®Google Scholar
• Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res 2010;35:295–301.
   PubMed Web of Science ®Google Scholar
• Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 2010;248:243–248.
   PubMed Web of Science ®Google Scholar
• Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004;137:62–69.
   PubMed Web of Science ®Google Scholar
• Holekamp NM. The vitreous gel: more than meets the eye. Am J Ophthalmol 2010;149:32–36.
   PubMed Web of Science ®Google Scholar
• Macedo B, Magalhães J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res 2010;62:514–522.
   PubMed Web of Science ®Google Scholar
• Macedo B, Batista AR, do Amaral JB, Saraiva MJ. Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Mol Med 2007;13:584–591.
   PubMed Web of Science ®Google Scholar
• Teixeira PF, Cerca F, Santos SD, Saraiva MJ. Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem 2006;281:21998–22003.
   PubMedGoogle Scholar
• Saraiva MJ. Cellular consequences of transthyretin deposition. Amyloid 2003;10 Suppl 1:13–16.
   PubMedGoogle Scholar
• Fiszman ML, Di Egidio M, Ricart KC, Repetto MG, Borodinsky LN, Llesuy SF, Saizar RD, et al. Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. Arch Neurol 2003;60:593–597.
   PubMedGoogle Scholar
• Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000;19:323–344.
   PubMed Web of Science ®Google Scholar
• Quintas A, Saraiva MJ, Brito RM. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem 1999;274:32943–32949.
   PubMed Web of Science ®Google Scholar
• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583–596.
   PubMed Web of Science ®Google Scholar
• Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001;159:1993–2000.
   PubMed Web of Science ®Google Scholar
• Zenkel M, Lewczuk P, Jünemann A, Kruse FE, Naumann GO, Schlötzer-Schrehardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol 2010;176:2868–2879.
   PubMed Web of Science ®Google Scholar
• Brown CM, Dütsch M, Michelson G, Neundörfer B, Hilz MJ. Impaired cardiovascular responses to baroreflex stimulation in open-angle and normal-pressure glaucoma. Clin Sci 2002;102:623–630.
   Google Scholar
• Clark CV, Mapstone R. Systemic autonomic neuropathy in open-angle glaucoma. Doc Ophthalmol 1986;64:179–185.
   PubMedGoogle Scholar
• Kumar R, Ahuja VM. A study of changes in the status of autonomic nervous system in primary open angle glaucoma cases. Indian J Med Sci 1999;53:529–534.
   PubMedGoogle Scholar
• Riccadonna M, Covi G, Pancera P, Presciuttini B, Babighian S, Perfetti S, Bonomi L, Lechi A. Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma 2003;12:156–163.
   PubMedGoogle Scholar
• Reiss GR, Lee DA, Topper JE, Brubaker RF. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984;25:776–778.
   PubMed Web of Science ®Google Scholar
• Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693–698.
   PubMed Web of Science ®Google Scholar
• Coutinho CA, Conceição I, Almeida A, Cantinho G, Sargento L, Vagueiro MC. Early detection of sympathetic myocardial denervation in patients with familial amyloid polyneuropathy type I. Rev Port Cardiol 2004;23:201–211.
   PubMedGoogle Scholar
• Davies DR, Smith SE. Pupil abnormality in amyloidosis with autonomic neuropathy. J Neurol Neurosurg Psychiatr 1999;67:819–822.
   PubMed Web of Science ®Google Scholar
• Carvalho MJ, van Den Meiracker AH, Boomsma F, Lima M, Freitas J, Veld AJ, Falcao De Freitas A. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 2000;35:892–897.
   PubMed Web of Science ®Google Scholar
• Pandit A, Gangurde S, Gupta SB. Autonomic failure in primary amyloidosis. J Assoc Physicians India 2008;56:995–996.
   PubMedGoogle Scholar
• Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288–300.
   PubMed Web of Science ®Google Scholar
• Gherghel D, Hosking SL, Orgül S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004;49:491–508.
   PubMedGoogle Scholar